Venture capital designed for drug discovery success
Curie.Bio is a venture capital firm and therapeutics accelerator investing at seed stage, acting as a drug discovery co-pilot for founders by combining capital with hands-on scientific support from a team of over 100 experts who have developed 44 approved medicines and 100+ in trials.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJan 2025
Jun 2024
Jan 2023
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Uses AI to analyze natural chemistry and accelerate discovery of new medicines for biopharma and ...
Biopharmaceutical company pioneering Helicon peptide drugs to target previously undruggable prote...
